Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-16 4:42 pm Purchase |
2025-05-09 | 13G | Apellis Pharmaceuticals, Inc. APLS |
Deep Track Capital, LP | 7,000,000 5.570% |
1,000,000 (+16.67%) |
Filing History |
| 2025-05-15 08:47 am Sale |
2025-03-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Deep Track Capital, LP | 5,576,558 6.390% |
-523,442 (-8.58%) |
Filing History |
| 2025-05-15 08:46 am Sale |
2025-03-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Deep Track Capital, LP | 3,442,833 5.040% |
-557,167 (-13.93%) |
Filing History |
| 2025-05-15 08:45 am Purchase |
2025-03-31 | 13G | Ocular Therapeutix, Inc. OCUL |
Deep Track Capital, LP | 15,458,138 9.650% |
6,227,369 (+67.46%) |
Filing History |
| 2025-05-15 08:44 am Purchase |
2025-03-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 5,500,000 7.210% |
1,375,000 (+33.33%) |
Filing History |
| 2025-05-15 08:43 am Sale |
2025-03-31 | 13G | Mind Medicine (MindMed) Inc. MNMD |
Deep Track Capital, LP | 6,500,000 8.190% |
-166,667 (-2.50%) |
Filing History |
| 2025-05-15 08:43 am Sale |
2025-03-31 | 13G | Invivyd, Inc. IVVD |
Deep Track Capital, LP | 9,722,254 8.100% |
-1,231,683 (-11.24%) |
Filing History |
| 2025-05-15 08:42 am Purchase |
2025-03-31 | 13G | Structure Therapeutics Inc. GPCR |
Deep Track Capital, LP | 12,300,000 7.150% |
3,300,000 (+36.67%) |
Filing History |
| 2025-05-15 08:41 am Sale |
2025-03-31 | 13G | Guardant Health, Inc. GH |
Deep Track Capital, LP | 5,443,721 4.410% |
-1,136,536 (-17.27%) |
Filing History |
| 2025-05-15 08:39 am Purchase |
2025-03-31 | 13G | 89bio, Inc. ETNB |
Deep Track Capital, LP | 13,816,333 9.180% |
7,338,384 (+113.28%) |
Filing History |
| 2025-05-15 08:38 am Unchanged |
2025-03-31 | 13G | Context Therapeutics Inc. CNTX |
Deep Track Capital, LP | 7,419,355 8.270% |
0 (Unchanged) |
Filing History |
| 2025-05-15 08:37 am Sale |
2025-03-31 | 13G | Bicycle Therapeutics plc BCYC |
Deep Track Capital, LP | 2,821,171 5.670% |
-509,065 (-15.29%) |
Filing History |
| 2025-05-15 08:36 am Purchase |
2025-03-31 | 13G | Allakos Inc. ALLK |
Deep Track Capital, LP | 7,232,701 8.020% |
4,721,965 (+188.07%) |
Filing History |
| 2025-05-13 4:32 pm Purchase |
2025-05-06 | 13G | Oruka Therapeutics, Inc. ORKA |
Deep Track Capital, LP | 1,896,780 5.070% |
1,896,780 (New Position) |
Filing History |
| 2025-04-10 4:14 pm Purchase |
2025-04-03 | 13G | Protagonist Therapeutics, Inc. PTGX |
Deep Track Capital, LP | 3,250,000 5.290% |
3,250,000 (New Position) |
Filing History |
| 2025-03-26 4:09 pm Purchase |
2025-03-19 | 13G | Immunovant, Inc. IMVT |
Deep Track Capital, LP | 9,500,000 5.590% |
8,500,000 (+850.00%) |
Filing History |
| 2025-03-25 4:06 pm Purchase |
2025-03-18 | 13G | Geron Corporation GERN |
Deep Track Capital, LP | 35,000,000 5.500% |
27,424,951 (+362.04%) |
Filing History |
| 2025-03-24 4:08 pm Purchase |
2025-03-17 | 13G | Dianthus Therapeutics, Inc. DNTH |
Deep Track Capital, LP | 2,357,702 7.340% |
2,357,702 (New Position) |
Filing History |
| 2025-02-19 9:51 pm Unchanged |
2025-02-18 | 13D | Dynavax Technologies Corporation DVAX |
Deep Track Capital, LP | 17,791,486 13.500% |
0 (Unchanged) |
Filing History |
| 2025-02-14 4:32 pm Purchase |
2025-02-07 | 13G | Ikena Oncology, Inc. IKNA |
Deep Track Capital, LP | 2,515,513 5.210% |
2,515,513 (New Position) |
Filing History |